Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
23.50 DKK
100.99 B DKK
290.40 B DKK
3.16 B
About NOVO NORDISK B A/S
Sector
Industry
CEO
Lars Fruergaard Jørgensen
Website
Headquarters
Bagsværd
Founded
1931
ISIN
DK0062498333
FIGI
BBG000F8TZ33
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Novo 1h longShould get up and at least break the neckline from the bigger SHS/IHS.
Stop below zone or lower trendline.
NVO buyThis downturn has been influenced by several factors:
Leadership Changes: CEO Lars Fruergaard Jørgensen is stepping down after eight years, following a sharp decline in the company's stock price.
STAT
+8
MarketWatch
+8
WSJ
+8
Increased Competition: Eli Lilly's weight-loss drugs, Mounjaro and Zepb
NOV - CONTINUATION OF A DOWNTREND OR START OF A NEWGood Morning,
Hope all is well. NVO has been in a down trend since Feb 26 2025, like most stocks. NVO tried to move past the 70$ price point however it was rejected and is now seeking lower support. Currently for trend there is an ascending channel. A break above the mid-line is bullish, a failure
NVO entering a great buying zoneNOVO has entered into the golden retracement for and good buying zone.
Looking to buy between 62.50 and 60.
Sell targets $90, 110 and 135.
Novo Nordisk Stock Chart Fibonacci Analysis 050925Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 411/61.80%
Chart time frame: D
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
NVO - looking for move upMy MVP system
M: rsi bottoming, rounded w a higher low
V: solid increase in vol
P: steep downward channel; could have nice pop to the upside; I would like the price better if it were forming a base instead of a steep down path, though price did hit a prior support/resistance zone
*Im wondering if
NVO-Buy here, thank me a year laterNVO at golden buy zone
Currently Bouncing off 100 Monthly SMA roughly 55% discount from its ATH
Now is a great time for buy long term hold IMO
Novo Nordisk (NVO) – Oversold Reversal + Earnings CatalystNovo Nordisk (NVO) has declined 61.13% from its all-time high of $148 (June 2024), finding support at $57.55. Over the past two weeks, the stock has rebounded over 15%, currently trading around $66.30, with strong reversal signals just ahead of earnings.
This setup presents a compelling opportunity
NVO Thesis earningsEarnings from LLY proved to be good on their fat drugs with concerns on tariffs for other items in their portfolio. Knowing that NVO is primary obesity with deals on the table from CVS and HIMS it is in the line of thinking that earnings will be in line with positive guidance in anticipation of mar
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where NOVO_B is featured.
Related stocks
Frequently Asked Questions
The current price of NOVO_B is 453.65 DKK — it has decreased by −2.41% in the past 24 hours. Watch NOVO NORDISK B A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange NOVO NORDISK B A/S stocks are traded under the ticker NOVO_B.
NOVO_B stock has risen by 1.43% compared to the previous week, the month change is a 10.86% rise, over the last year NOVO NORDISK B A/S has showed a −50.71% decrease.
We've gathered analysts' opinions on NOVO NORDISK B A/S future price: according to them, NOVO_B price has a max estimate of 900.00 DKK and a min estimate of 350.00 DKK. Watch NOVO_B chart and read a more detailed NOVO NORDISK B A/S stock forecast: see what analysts think of NOVO NORDISK B A/S and suggest that you do with its stocks.
NOVO_B reached its all-time high on Jun 26, 2024 with the price of 1,033.20 DKK, and its all-time low was 0.85 DKK and was reached on Mar 28, 1988. View more price dynamics on NOVO_B chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NOVO_B stock is 3.36% volatile and has beta coefficient of 1.41. Track NOVO NORDISK B A/S stock price on the chart and check out the list of the most volatile stocks — is NOVO NORDISK B A/S there?
Today NOVO NORDISK B A/S has the market capitalization of 2.01 T, it has increased by 0.91% over the last week.
Yes, you can track NOVO NORDISK B A/S financials in yearly and quarterly reports right on TradingView.
NOVO NORDISK B A/S is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
NOVO_B earnings for the last quarter are 6.53 DKK per share, whereas the estimation was 6.11 DKK resulting in a 6.95% surprise. The estimated earnings for the next quarter are 5.97 DKK per share. See more details about NOVO NORDISK B A/S earnings.
NOVO NORDISK B A/S revenue for the last quarter amounts to 78.09 B DKK, despite the estimated figure of 77.94 B DKK. In the next quarter, revenue is expected to reach 77.73 B DKK.
NOVO_B net income for the last quarter is 29.03 B DKK, while the quarter before that showed 28.23 B DKK of net income which accounts for 2.85% change. Track more NOVO NORDISK B A/S financial stats to get the full picture.
NOVO NORDISK B A/S dividend yield was 1.83% in 2024, and payout ratio reached 50.28%. The year before the numbers were 1.35% and 50.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 29, 2025, the company has 76.3 K employees. See our rating of the largest employees — is NOVO NORDISK B A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVO NORDISK B A/S EBITDA is 156.83 B DKK, and current EBITDA margin is 50.95%. See more stats in NOVO NORDISK B A/S financial statements.
Like other stocks, NOVO_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVO NORDISK B A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVO NORDISK B A/S technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVO NORDISK B A/S stock shows the neutral signal. See more of NOVO NORDISK B A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.